NASA Goddard Space Flight Center's Dr. Jennifer Wiseman explains the Hubble Space Telescope's view of the Pillars of Creation, located in the Eagle Nebula. Credit: NASA's Goddard Space Flight Center ...
Detailed price information for Transcode Therapeutics Inc (RNAZ-Q) from The Globe and Mail including charting and trades.
Bangkok Post on MSN
Contractor blames whirlwind for dome's collapse
Thai Engineering and Construction Plc, the contractor for the collapsed dome building in Samut Prakan, has blamed unusually strong and gusty wind for the incident, which injured four workers on Monday ...
A partnership comprising TransCode Therapeutics and Quantum Leap Healthcare Collaborative has submitted an investigational ...
Submits IND Amendment For Planned Phase 2A Trial Of TTX-MC138 In Colorectal Cancer. TransCode Therapeutics (NASDAQ: RNAZ) announced the submission of an Investigational New Drug (“IND”) application ...
TransCode Therapeutics, Inc., en collaboration avec Quantum Leap Healthcare Collaborative , a annoncé le dépôt auprès de la ...
TransCode Therapeutics, Inc. (NASDAQ: RNAZ) (TransCode), a clinical stage company pioneering immuno-oncology and RNA therapeutics ...
Investing.com -- L’action TransCode Therapeutics (NASDAQ:RNAZ) a bondi de 40% après que la société a annoncé la soumission d’un amendement à sa demande de nouveau médicament expérimental (IND) auprès ...
TransCode Therapeutics, Inc. (NASDAQ: RNAZ) (TransCode), a clinical stage company pioneering immuno-oncology and RNA therapeutics for the treatment of high risk and advanced cancers, in collaboration ...
Glioblastoma is the most aggressive primary brain cancer, with median survival under two years from diagnosis despite current standard-of-care interventions. The molecular target of TTX-MC138, ...
TransCode Therapeutics ( (RNAZ)) just unveiled an announcement. On December 19, 2025, TransCode Therapeutics appointed veteran life sciences executive Jack E. Stover to its board of directors, ...
BOSTON - TransCode Therapeutics, Inc. (NASDAQ:RNAZ), a clinical stage company focused on immuno-oncology and RNA treatments for advanced cancer, announced Monday the appointment of Jack E. Stover to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results